These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up. Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496 [TBL] [Abstract][Full Text] [Related]
4. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Finckh A; Ciurea A; Brulhart L; Kyburz D; Möller B; Dehler S; Revaz S; Dudler J; Gabay C; Arthritis Rheum; 2007 May; 56(5):1417-23. PubMed ID: 17469098 [TBL] [Abstract][Full Text] [Related]
5. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Söderlin MK; Petersson IF; Geborek P Scand J Rheumatol; 2012 Feb; 41(1):1-9. PubMed ID: 22118371 [TBL] [Abstract][Full Text] [Related]
6. Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis. Popa C; Netea MG; de Graaf J; van den Hoogen FH; Radstake TR; Toenhake-Dijkstra H; van Riel PL; van der Meer JW; Stalenhoef AF; Barrera P J Rheumatol; 2009 Apr; 36(4):724-30. PubMed ID: 19273452 [TBL] [Abstract][Full Text] [Related]
7. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers]. Benucci M; Turchini S; Parrochi P; Boccaccini P; Manetti R; Cammelli E; Manfredi M Recenti Prog Med; 2006 Mar; 97(3):134-9. PubMed ID: 16700418 [TBL] [Abstract][Full Text] [Related]
8. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Metsios GS; Stavropoulos-Kalinoglou A; Douglas KM; Koutedakis Y; Nevill AM; Panoulas VF; Kita M; Kitas GD Rheumatology (Oxford); 2007 Dec; 46(12):1824-7. PubMed ID: 18032540 [TBL] [Abstract][Full Text] [Related]
9. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027 [TBL] [Abstract][Full Text] [Related]
10. Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment. Renzo LD; Saraceno R; Schipani C; Rizzo M; Bianchi A; Noce A; Esposito M; Tiberti S; Chimenti S; DE Lorenzo A Dermatol Ther; 2011; 24(4):446-51. PubMed ID: 21910803 [TBL] [Abstract][Full Text] [Related]
11. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Listing J; Strangfeld A; Kekow J; Schneider M; Kapelle A; Wassenberg S; Zink A Arthritis Rheum; 2008 Mar; 58(3):667-77. PubMed ID: 18311816 [TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Van Doornum S; McColl G; Wicks IP Rheumatology (Oxford); 2005 Nov; 44(11):1428-32. PubMed ID: 16076882 [TBL] [Abstract][Full Text] [Related]
13. TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study. Toussirot É; Mourot L; Dehecq B; Wendling D; Grandclément É; Dumoulin G; Eur J Nutr; 2014 Apr; 53(3):951-61. PubMed ID: 24173963 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of decoy receptor- and antibody-mediated tumour necrosis factor blockage on FoxP3 expression in responsive arthritis patients. Ryder LR; Ryder LP; Bartels EM; Woetmann A; Madsen HO; Ødum N; Danneskiold-Samsøe B; Ribel-Madsen S; Bliddal H APMIS; 2013 Apr; 121(4):337-47. PubMed ID: 23031059 [TBL] [Abstract][Full Text] [Related]